Clinical trial
GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke…
NCT00738894 · W.L.Gore & Associates, Industry · Completed
Key facts
| NCT number | NCT00738894 |
|---|---|
| Title | GORE® Septal Occluder Device for Patent Foramen Ovale (PFO) Closure in Stroke Patients |
| Official title | GORE® HELEX® Septal Occluder / GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke or Imaging-Confirmed TIA in Patients With Patent Foramen Ovale (PFO) - The Gore REDUCE Clinical Study |
| Acronym | REDUCE |
| Lead sponsor | W.L.Gore & Associates, Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Stroke, Transient Ischemic Attack |
| Intervention type | Device, Drug |
| Interventions | Septal Occluder Device, Antiplatelet Medical Therapy |
| Enrollment | 664 |
| Start date | Dec 10, 2008 |
| Primary completion | Apr 24, 2017 |
| Completion | May 11, 2020 |
| First posted | Aug 21, 2008 |
| Last update posted | Nov 20, 2020 |
| Countries | Denmark, United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- 1–9 Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: